UiPath Inc. (NYSE: PATH) stock fell -1.07% on Friday to $17.56 against a previous-day closing price of $17.75. With 10.93 million shares changed hands, the volume of the stock remained heavier than its average volume of 8.12 million shares. During the session, the Software – Infrastructure company that operates in wider Technology sector, reached to the highest price of $17.76 whereas the lowest price it dropped to was $17.12. The 52-week range on PATH shows that it touched its highest point at $19.94 and its lowest point at $10.40 during that stretch. It currently has a 1-year price target of $19.60. Beta for the stock currently stands at 0.68.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PATH was down-trending over the past week, with a drop of -4.98%, but this was up by 14.85% over a month. Three-month performance dropped to -6.35% while six-month performance rose 1.97%. The stock gained 22.54% in the past year, while it has gained 38.16% so far this year. A look at the trailing 12-month EPS for PATH yields -0.32 with Next year EPS estimates of 0.47. For the next quarter, that number is 0.07. This implies an EPS growth rate of 48.20% for this year and 13.35% for next year.
Float and Shares Shorts:
At present, 562.88 million PATH shares are outstanding with a float of 433.29 million shares on hand for trading. On Aug 30, 2023, short shares totaled 43.65 million, which was 7.70% higher than short shares on Jul 30, 2023. In addition to Mr. Daniel Solomon Dines as the firm’s Co-Founder, Co-CEO & Chairman, Mr. Robert Enslin serves as its Co-Chief Exec. Officer.
Through their ownership of 63.75% of PATH’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 34.25% of PATH, in contrast to 31.12% held by mutual funds. Shares owned by individuals account for 12.41%. As the largest shareholder in PATH with 10.09% of the stake, ARK Investment Management LLC holds 48,280,787 shares worth 48,280,787. A second-largest stockholder of PATH, The Vanguard Group, Inc., holds 34,303,615 shares, controlling over 7.17% of the firm’s shares. Nikko Asset Management Co., Ltd. is the third largest shareholder in PATH, holding 26,235,937 shares or 5.48% stake. With a 5.91% stake in PATH, the ARK Innovation ETF is the largest stakeholder. A total of 28,274,141 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 2.19% of PATH stock, is the second-largest Mutual Fund holder. It holds 10,477,190 shares valued at 165.64 million. Vanguard Small Cap Index Fund holds 1.82% of the stake in PATH, owning 8,713,377 shares worth 137.76 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PATH since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With PATH analysts setting a high price target of $25.00 and a low target of $16.00, the average target price over the next 12 months is $19.69. Based on these targets, PATH could surge 42.37% to reach the target high and fall by -8.88% to reach the target low. Reaching the average price target will result in a growth of 12.13% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded PATH stock several times over the past three months with 0 Buys and 27 Sells. In these transactions, 0 shares were bought while 508,351 shares were sold. The number of buy transactions has increased to 18 while that of sell transactions has risen to 158 over the past year. The total number of shares bought during that period was 4,061,745 while 47,082,289 shares were sold.